Best Canadian Stocks to Buy With $7,000 Right Now [Yahoo! Finance Canada]
Aurinia Pharmaceuticals Inc - Common Shares (AUPH)
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.auriniapharma.com
Company Research
Source: Yahoo! Finance Canada
Investing in high-quality stocks poised to steadily increase free cash flow (FCF) is a proven strategy for generating outsized returns over time. In this article, I have identified two such Canadian stocks you can buy with $7,000 right now. Is this Canadian stock a good buy? Valued at a market cap of almost US$2 billion, Aurinia Pharmaceuticals NASDAQ:AUPH ) is a biopharmaceutical company that delivers therapies to people living with autoimmune diseases. It offers LUPKYNIS (voclosporin), an oral therapy that treats adult patients with active lupus nephritis. Aurinia Pharmaceuticals reported strong third-quarter results with LUPKYNIS sales climbing 27% year over year to US$70.6 million. Its solid numbers prompted management to raise full-year revenue guidance for the second time in 2025. The company now expects net product sales of US$265 million to US$270 million, up from its previous guidance of US$250 million to US$260 million, demonstrating continued commercial momentum fo
Show less
Read more
Impact Snapshot
Event Time:
AUPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUPH alerts
High impacting Aurinia Pharmaceuticals Inc - Common Shares news events
Weekly update
A roundup of the hottest topics
AUPH
News
- Investing in Aurinia Pharmaceuticals (NASDAQ:AUPH) a year ago would have delivered you a 80% gain [Yahoo! Finance]Yahoo! Finance
- Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- With 54% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns [Yahoo! Finance]Yahoo! Finance
- Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms [Seeking Alpha]Seeking Alpha
AUPH
Earnings
- 11/4/25 - Beat
AUPH
Sec Filings
- 2/3/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- AUPH's page on the SEC website